Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

Treatment of rheumatoid arthritis with electromagnetic millimeter waves applied to acupuncture points -- a randomized double blind clinical study
Usichenko TI, Ivashkivsky OI, Gizhko VV
Acupuncture & Electro-Therapeutics Research 2003;28(1-2):11-18
clinical trial
4/10 [Eligibility criteria: No; Random allocation: Yes; Concealed allocation: No; Baseline comparability: No; Blind subjects: Yes; Blind therapists: Yes; Blind assessors: Yes; Adequate follow-up: No; Intention-to-treat analysis: No; Between-group comparisons: No; Point estimates and variability: No. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed*

The aim of the study was to evaluate the efficacy and safety of electromagnetic millimeter waves (MW) applied to acupuncture points in patients with rheumatoid arthritis (RA). Twelve patients with RA were exposed to MW with power 2.5 mW and band frequency 54 to 64 GHz. MW were applied to the acupuncture points of the affected joints in a double blind manner. At least 2 and maximum 4 points were consecutively exposed to MW during one session. Total exposure time consisted of 40 minutes. According to the study design, group I received only real millimeter wave therapy (MWT) sessions, group II only sham sessions. Group III was exposed to MW in a random cross-over manner. Pain intensity, joint stiffness and laboratory parameters were recorded before, during and immediately after the treatment. The study was discontinued because of beneficial therapeutic effects of MWT. Patients from group I (n = 4) reported significant pain relief and reduced joint stiffness during and after the course of therapy. Patients from group II (n = 4) revealed no improvement during the study. Patients from group III reported the changes of pain and joint stiffness only after real MW sessions. After further large-scale clinical investigations MWT may become a non-invasive adjunct in therapy of patients with RA.
With permission from Cognizant Communication Corporation, 3 Hartsdale Rd, Elmsford NY 10523-3701, USA.

Full text (sometimes free) may be available at these link(s):      help